Catherine Rolland is an experienced research scientist currently at PPD since February 2022, previously serving as Senior Scientific Director and Scientific Director at Envision Pharma Group from October 2015 to March 2022. Rolland has extensive expertise in scientific methodology and strategic development across various therapeutic areas, including cardiovascular and metabolic disorders, oncology, autoimmune diseases, and type 2 diabetes. Notable achievements include generating significant quarterly revenues, managing complex projects from inception to publication, and maintaining collaborative networks with high-profile clients and key opinion leaders. Prior to Envision, Rolland worked as a nutrition consultant and lecturer, focusing on weight loss, obesity, and related health issues. Educational qualifications include a PhD in Clinical Biochemistry from the University of Aberdeen and additional degrees in Human Nutrition and Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices